HSBC Holdings
CGON icon

HSBC Holdings’s CG Oncology CGON Stock Holding History

HSBC Holdings’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
175,765
-12,000
-6% -$784K 0.01% 907
2026
Q1 		$12.7M Buy
+187,765
New +$10.6M 0.01% 867
2024
Q4 		– Sell
-5,792
Closed -$222K – 3108
2024
Q3 		$222K Buy
+5,792
New +$203K ﹤0.01% 2546

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HSBC Holdings's CGON Position: Q2 2026 in Review

HSBC Holdings reduced its CG Oncology (CGON) stake by 6.4% in Q2 2026, selling an estimated $784K and leaving 175,765 shares worth $12.5M. The position accounts for 0.01% of the portfolio, ranked #907.

HSBC Holdings first reported a position in CGON in Q3 2024 and has held it in 3 quarters since. The position peaked at $12.7M in Q1 2026. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • HSBC Holdings held 175,765 shares of CG Oncology worth $12.5M as of Q2 2026.
  • HSBC Holdings sold 12,000 CG Oncology shares in Q2 2026, an estimated $784K.
  • CG Oncology made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #907 holding.
  • HSBC Holdings first reported a position in CG Oncology in Q3 2024 and has held it in 3 quarters since.
  • HSBC Holdings's CG Oncology position peaked at $12.7M in Q1 2026.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.